Furthermore, Kaplan-Meier survival analysis indicated that the high MYBL2 expression group had significantly poorer outcomes in overall survival, disease-specific survival, disease-free interval, and progression-free interval compared to the low expression group, suggesting a close association between high MYBL2 expression and poor prognosis in endometrial cancer. This evidence concerns the gene MYBL2 and endometrial cancer.